Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. (2022)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-22-0305
PubMed Identifier: 35552673
Publication URI: http://europepmc.org/abstract/MED/35552673
Type: Journal Article/Review
Volume: 28
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 16
ISSN: 1078-0432